What is the glass transition temperature (Tg') and why is it important in freeze-drying?

Tg' is the temperature at which the maximally freeze-concentrated solute phase transitions from a glassy to a rubbery state. If product temperature exceeds Tg' during primary drying, collapse can occur, compromising cake structure and reconstitution. We determine Tg' by DSC and ensure the cycle stays well below it.

How do you determine the optimal primary drying conditions for my product?

We combine DSC measurements of collapse temperature with a heat and mass transfer model to calculate the maximum allowable product temperature. A design of experiments (DOE) around shelf temperature and chamber pressure identifies the combination that minimizes drying time while staying within safety margins. We verify with in-process temperature probes.

Do you offer scale-up support for commercial freeze-dryers?

Yes. Our service includes pilot-scale runs on representative lyophilizers, measurement of heat transfer coefficients, and assessment of shelf temperature uniformity. We provide a transfer report with recommended parameters for your target manufacturing equipment.

What analytical methods do you use to characterize the freeze-dried product?

Our standard suite includes differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), scanning electron microscopy (SEM), X-ray powder diffraction (XRPD), near-infrared (NIR) moisture analysis, and Karl Fischer titration. These methods provide a complete picture of cake morphology, solid state, and residual moisture.

How do you ensure the cycle is robust for batch manufacture?

We perform edge-of-failure studies by deliberately varying critical process parameters (e.g., ±2°C shelf temperature, ±20 mTorr chamber pressure) and confirming that CQAs remain within specifications. This defines an acceptable design space that accommodates normal process variability.

Services

Online Inquiry

Name *

Email *

Subject *

Phone

Your Message

How Did You Hear About Us

Freeze-Drying Process Development and Optimization

Biopharmaceutical Drying Services

Freeze-drying (lyophilization) removes water from temperature-sensitive biologics by freezing the product below its glass transition.

Cycle development from formulation through secondary drying
Excipient screening and optimization for stability and reconstitution
Quality-by-design (QbD) approach with critical quality attributes
Process analytical technology (PAT) and model-based optimization
Seamless scale-up from lab to pilot and commercial lyophilizers

Optimize Your Cycle

Why Trust Our Freeze-Drying Expertise?

We combine deep mechanistic understanding of lyophilization with hands-on experience across hundreds of biologic programs, ensuring your product achieves the stability profile it needs.

Proven track record across mAbs, vaccines, enzymes, and nanoparticles
Advanced analytical suite for real-time moisture and collapse temperature
Customized excipient strategies using sugars, polyols, surfactants
Regulatory-aware documentation for IND and BLA submissions

Reliable

Compliant

Precise

Our Methodology

Systematic Lyophilization Cycle Optimization

Our approach integrates formulation science, process engineering, and real-time analytics to deliver a robust, transferable freeze-drying cycle for your biologic.

Core Cycle Development

We optimize each lyophilization stage—freezing, primary drying, and secondary drying—against your product's critical quality attributes (CQAs).

Glass transition (Tg') and eutectic temperature determination by DSC
Controlled ice nucleation for batch uniformity
Primary drying shelf temperature and chamber pressure DOE
Secondary drying temperature ramp and endpoint moisture targeting

Formulation & Excipient Design

A successful freeze-drying cycle starts with the right formulation. We select and optimize bulking agents, stabilizers, and cryoprotectants to maximize product stability and elegance.

Screening of sugars (sucrose, trehalose), polyols (mannitol), and surfactants
Impact of excipient concentration on collapse temperature and reconstitution
Minimization of cake shrinkage and cracking
Compatibility testing with drug substance and container closure system

Quality by Design

We apply QbD principles to identify critical process parameters (CPPs) and establish a design space that ensures consistent product CQAs across batches.

Analytical Characterization

Our analytical suite (DSC, TGA, SEM, XRPD, NIR, Karl Fischer) provides mechanistic insights into freeze-dried cake morphology, residual moisture, solid-state form, and reconstitution time.

Scale-Up & Transfer

We leverage engineering models and pilot-scale runs to ensure your optimized cycle transfers smoothly to commercial freeze-dryers, with documented heat and mass transfer coefficients.

What You Receive

Comprehensive Freeze-Drying Service Deliverables

From a detailed development report to a validated cycle recommendation, our deliverables support your regulatory filings and manufacturing readiness.

Data & Cycle Parameters

Full development report with all raw data and experimental design
Optimized freezing, primary drying, and secondary drying profiles
Critical quality attribute (CQA) summary (moisture, reconstitution time, cake appearance)
Process parameter ranges for scale-up (shelf temperature, chamber pressure, ramp rates)

Reporting & Support

Excipient rationale and formulation recommendation
Regulatory supporting documentation (CQA/CPP risk assessment, design space maps)
Scale-up guidance including freeze-dryer suitability assessment
Ongoing technical support during technology transfer and process validation

Service Scope

Tailored Freeze-Drying Solutions

Each project is scoped to your molecule, stage, and goals. The table below illustrates typical parameters and options available for customization.

Parameter	Typical Project Scope
Formulation excipient selection	Common excipient classes include sugars (sucrose, trehalose), polyols (mannitol, sorbitol), surfactants (polysorbate 80), bulking agents, and buffering systems, selected based on the target product profile.
Freezing protocol	Ramp rate (0.5–5 °C/min), hold temperature (typically –40 to –50 °C), annealing step, controlled ice nucleation via depressurization
Primary drying design space	Shelf temperature (–30 to –10 °C), chamber pressure (50–150 mTorr), duration estimated from heat/mass transfer modeling
Secondary drying conditions	Ramp rate (0.1–1 °C/min), final shelf temperature (20–40 °C), endpoint moisture target (scoped per project, confirmed by Karl Fischer)
Analytical characterization	Analytical characterization typically includes DSC (Tg', Tg, Tc), TGA for mass change, SEM for cake morphology, XRPD for solid form, moisture content via Karl Fischer or NIR, and reconstitution time measurement.
Cycle robustness testing	Edge-of-failure studies around CPPs, short-term accelerated stability, design space verification
Scale-up support	Pilot runs at 0.1–5 L fill volume, heat transfer coefficient (Kv) measurement, lyophilizer mapping (shelf temperature uniformity)
Regulatory documentation	CQA/CPP matrix, risk assessments, cycle development summary for IND/IMPD/BLA sections

Our Process

From Molecule to Robust Lyophilization Cycle

Our five-stage workflow ensures every parameter is optimized based on data, not guesswork, delivering a cycle ready for clinical or commercial manufacturing.

Formulation Design & Excipient Screening

We evaluate candidate excipients and their concentrations to maximize the glass transition temperature and collapse temperature of the frozen solution, balancing stability and drying efficiency.

Freezing Protocol Development

The product is frozen below its glass transition temperature (Tg') with controlled ramp rates; we optionally apply annealing or controlled ice nucleation to reduce vial-to-vial variability and improve primary drying uniformity.

Primary Drying Cycle Optimization

Using a combination of differential scanning calorimetry (DSC) data and mathematical modeling, we identify the optimal shelf temperature and chamber pressure that maximize sublimation rate while keeping product temperature below collapse.

Secondary Drying Moisture Desorption

We ramp the shelf temperature to 20–40 °C under vacuum to desorb bound water, targeting a residual moisture level scoped per project as confirmed by in-process measurement.

Analytical Confirmation & Cycle Locking

The final cycle is verified across multiple vials and freeze-dryer positions; we measure cake morphology, reconstitution time, moisture uniformity, and short-term stability to lock the process parameter set.

Applications

Freeze-Drying for Diverse Biologics

Our optimization platform handles a wide range of thermolabile products, from monoclonal antibodies to nanoparticle formulations.

Stabilize Your mAb with Minimal Aggregation

Monoclonal antibody formulations are highly sensitive to freezing and drying stresses. Our approach selects appropriate excipients (e.g., trehalose, sucrose) and gentle freezing profiles to maintain conformational integrity.

Minimize aggregation and subvisible particles
Target residual moisture scoped per project for long-term stability
Optimize reconstitution time under 5 minutes

Maintain Potency Through Freeze-Drying

Live-attenuated vaccines, inactivated viruses, and viral vectors require precise control of freezing and drying to preserve immunogenicity and particle integrity.

Cell culture supernatant or purified virus stabilization
Controlled ice nucleation to protect fragile particles
Cake appearance and potency retention as key CQAs

Protect Activity with Tailored Cycles

Enzymes often lose activity upon freeze-drying due to unfolding and aggregation. We design cycles that stay below the product's specific collapse temperature and incorporate protective excipients.

Activity recovery scoped per project after reconstitution
Custom excipient cocktails (sugars, amino acids, polymers)
Secondary drying conditions that avoid over-drying

Prevent Aggregation in Dried State

Colloidal carriers can aggregate during freeze-drying. Our formulation and cycle optimization ensures particle size and drug loading remain intact after reconstitution.

Lyoprotectant selection (sucrose, trehalose, hydroxypropyl-β-cyclodextrin)
Slow freezing to control ice crystal size
Residual moisture monitoring to maintain critical quality attributes

Frequently Asked Questions

Freeze-Drying Optimization Clarified

Common questions about our approach, deliverables, and how we tailor lyophilization cycles to your biologic.

Tg' is the temperature at which the maximally freeze-concentrated solute phase transitions from a glassy to a rubbery state. If product temperature exceeds Tg' during primary drying, collapse can occur, compromising cake structure and reconstitution. We determine Tg' by DSC and ensure the cycle stays well below it.
We combine DSC measurements of collapse temperature with a heat and mass transfer model to calculate the maximum allowable product temperature. A design of experiments (DOE) around shelf temperature and chamber pressure identifies the combination that minimizes drying time while staying within safety margins. We verify with in-process temperature probes.
Yes. Our service includes pilot-scale runs on representative lyophilizers, measurement of heat transfer coefficients, and assessment of shelf temperature uniformity. We provide a transfer report with recommended parameters for your target manufacturing equipment.
Our standard suite includes differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), scanning electron microscopy (SEM), X-ray powder diffraction (XRPD), near-infrared (NIR) moisture analysis, and Karl Fischer titration. These methods provide a complete picture of cake morphology, solid state, and residual moisture.
We perform edge-of-failure studies by deliberately varying critical process parameters (e.g., ±2°C shelf temperature, ±20 mTorr chamber pressure) and confirming that CQAs remain within specifications. This defines an acceptable design space that accommodates normal process variability.

Scientific Literature

References

Mehanna MM, Abla KK. Recent advances in freeze-drying: variables, cycle optimization, and innovative techniques. Pharmaceutical development and technology. 2022;27(8):904-923. View on PubMed
Trenkenschuh E, Friess W. Freeze-drying of nanoparticles: How to overcome colloidal instability by formulation and process optimization. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 2021;165:345-360. View on PubMed
Durán-Lobato M, Tovar S, de Oliveira Diz T, et al. Formulation of protein-loaded nanoparticles via freeze-drying. Drug delivery and translational research. 2024;14(12):3640-3653. View on PubMed
Bermúdez-Gómez P, Fernández-López J, Pérez-Clavijo M, et al. Optimization of Mushroom (Agaricus bisporus and Pleurotus ostreatus) By-Products Processing for Prospective Functional Flour Development. Foods (Basel, Switzerland). 2024;13(24). View on PubMed
Tran PHL, Lee BJ, Tran TTD. Strategies and formulations of freeze-dried tablets for controlled drug delivery. International journal of pharmaceutics. 2021;597:120373. View on PubMed
Soleymani Eil Bakhtiari S, Karbasi S. Keratin-containing scaffolds for tissue engineering applications: a review. Journal of biomaterials science. Polymer edition. 2024;35(6):916-965. View on PubMed

Please kindly note that our products and services are for research use only.